CAS: 960071-64-1 - 17,17'-(trisulfanediyldicarbonyl)bis(6α,9α-difluoro-11β-hydroxy-16α-methyl-3-oxoandrosta-17α-yl) dipropanoate
Description:C48H58F4O10S3
Formula:C48H58F4O10S3
- Synonyms:
- (6alpha,11beta,16alpha,17alpha)-(6'alpha,11'beta,16'alpha,17'alpha)-17,17'-(Trithiodicarbonyl)bis[6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-androsta-1,4-dien-3-one
Fluticasone Propionate Trisulfide
CAS:960071-64-1
Organo-sulfur compounds, nesoi
Formula:
C48H58F4O10S3
Color and Shape:
White Off-White Solid
Molecular weight:
966.31282
Estimated delivery in United States, on Tuesday 10 Dec 2024
Fluticasone Propionate EP Impurity I
CAS:960071-64-1
Formula:
C48H58F4O10S3
Color and Shape:
White To Off-White Solid
Molecular weight:
967.16
Ref: 4Z-F-0913
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
(6a,11b,16a,17a)-(6'a,11'b,16'a,17'a)-17,17'-(Trithiodicarbonyl)bis[6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-androsta-1,4-dien-3-one
CAS:960071-64-1
Impurity Fluticasone EP Impurity I Applications Dimerized impurity of Fluticasone propionate (F599500), a antiallergic, anti-asthmatic …
Formula:
C48H58F4O10S3
Color and Shape:
Neat
Molecular weight:
967.16
Ref: TR-T886430
10mg | 183.00 € | ||
25mg | 345.00 € | ||
100mg | 962.00 € |
Estimated delivery in United States, on Friday 20 Dec 2024
17,17'-(Trisulfanediyldicarbonyl)bis(6α,9-difluoro-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-yl) dipropanoate
CAS:960071-64-1
Please enquire for more information about 17,17'-(Trisulfanediyldicarbonyl)bis(6alpha,9-difluoro-11beta-hydroxy-16alpha-methyl-3-oxoandrosta-1,4-dien-17alpha-yl) dipropanoate including the price, delivery time and more …
Formula:
C48H58F4O10S3
Purity:
Min. 95%
Molecular weight:
967.2 g/mol
Ref: 3D-KNB07164
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information |